Navigation Links
San Diego-Based Wellaho Receives FDA Approval For its Mobile and Web Platform for Patients with Chronic Conditions
Date:2/19/2013

SAN DIEGO, Feb. 19, 2013 /PRNewswire/ -- Sanitas, Inc., a San Diego company developing mobile and web solutions for outpatients with chronic conditions, announced today that it has received approval from the US Food and Drug Administration, (FDA) as a 510(K) class II medical device for Wellaho, its proprietary mobile and web platform.

Wellaho's Personalized Outpatient Management SystemTM - currently deployed in a number of clinical studies at UC San Diego Health Services - is a physician-directed, web-based and mobile platform that allows providers to supervise and monitor patients between office visits in a secure, HIPAA compliant environment, while enabling patients to access their medical information, monitor their condition, stream relevant educational materials and connect securely to their doctors and healthcare team.

Naser Partovi , CEO of Sanitas, Inc., said of the Wellaho system, "Patients with chronic conditions need a web of care, coming from the best that providers and technology can offer. Given the tsunami of new apps and technologies that hit the market each year, both patients and providers need the highest validation for the products and services they use. Now, with the FDA's approval, Wellaho offers one more reason for providers and patients to trust that we can provide a safe, secure, and effective solution for managing their care."

About Sanitas, Inc.

Sanitas Inc. is a privately held San Diego company founded in 2010. Wellaho is the company's proprietary web and mobile platform serving patients with chronic conditions including: diabetes, congestive heart failure, kidney disease, COPD, asthma, hypertension, breast cancer, sleep disordered breathing, and obesity. Patients can view their health records (CCDs) and easily monitor their medications, weight, exercise and activity levels, blood glucose levels, blood pressure and other symptoms. Meanwhile, the patients' doctors and medical team can use Wellaho to monitor their patients' conditions between office visits.  Social networking and self-education are integral aspects of Wellaho's platform, allowing patients and their families to learn more about their disease while staying connected to their medical team in a secure, HIPPA compliant online environment.  Sanitas is actively engaged with UC San Diego Health Services in several clinical studies including diabetes, congestive heart failure and weight management.

For more information, please contact moya@wellaho.com


'/>"/>
SOURCE Sanitas, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
2. Leica Biosystems Receives FDA Approval for the Fully Automated Bond Oracle™ HER2 IHC System on the Leica BOND-MAX
3. Nephros Receives 510(k) Clearance for Hemodiafiltration System
4. ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System
5. BONESUPPORT Receives Red Herring 2012 Top 100 Europe Award
6. Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
7. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
8. Alexza Receives Complete Response Letter for Adasuve™ NDA
9. Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
10. Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering
11. New Chronic Wound Treatment Device Receives Award from Veterans Healthcare Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... 2017  AllianceRx Walgreens Prime, the combined central specialty ... pharmacy benefit manager Prime Therapeutics LLC (Prime), today officially ... the unveiling of new signage at its headquarters in ... at a few other company-owned facilities across the country. ... some of whom will begin to see the AllianceRx ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... that its MyDario product is expected to appear on The Dr. Oz ... Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked ... The segment features ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... communities in the greater Dallas, Miami, and Raleigh regions, is organizing an extended ... overcome a rare and deadly chromosome abnormality. , After struggling since birth with ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... certification process to promote standards of excellence for the field of eating disorders, ... March 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ...
(Date:10/13/2017)... ... 13, 2017 , ... Many families have long-term insurance that covers care for ... a waiver for care if the client has a cognitive impairment diagnosis. , ... care, is often waived, so the benefits from their insurance start immediately,” said Mechell ...
(Date:10/13/2017)... ... 2017 , ... Talented host, actor Rob Lowe, is introducing ... new episode of "Success Files," which is an award-winning educational program broadcasted on ... subject in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
Breaking Medicine News(10 mins):